Technical Update - Novo Nordisk uptrend stretched. A correction is looming Technical Update - Novo Nordisk uptrend stretched. A correction is looming Technical Update - Novo Nordisk uptrend stretched. A correction is looming

Technical Update - Novo Nordisk uptrend stretched. A correction is looming

Equities 3 minutes to read
KCL
Kim Cramer Larsson

Technical Analyst, Saxo Bank

Summary:  Novo may have topped out and could be facing a larger correction. Top and reversal patterns are in place but downtrend/correction not yet confirmed.


Novo Nordisk reported earnings this morning and the reception has been market indecision resulting in quite a lot of volatility.

Short-term: Novo formed a Bearish Engulfing candle 9th January which is an indication of a top and reversal. Market gapped lower the following day. However, the gap has been closed but the Bearish Engulfing top and reversal indication remains. It would need at close above 975 to be cancelled and reversed.
If Novo is hit by selling pressure and closes below 896.50 it is technically in a bearish trend. The lower gap from November will be a strong support area.
Daily RSI is still showing positive sentiment with no divergence indicating a push higher in Novo.
An RSI close above its falling trendline could be first indication of this scenario to play out. If RSI closes below 40 its in negative sentiment.

Source all charts and data: Saxo Group

Medium- and longer-term: Novo has formed a Bearish Engulfing candle a couple weeks ago after hitting the upper band in the rising channel. There has been RSI and Volume divergence during the entire uptrend from Q4 2021 i.e., the Strength Indicator and traded volume have been declining while the share price has been rising. That is a warning sign of a trend weakening.
If weekly RSI closes below its lower rising trend line it is indication of Nove could drop to test the lower rising trendline in the rising channel.

Monthly chart shows almost similar pattern as the weekly chart. Rising channel and declining RSI and Volume meaning divergence. The uptrend in price is weakening. Divergence on RSI cannot go on forever.
For these price exhaustion patterns to be cancelled and reverse a close above 976.30 is needed following new higher RSI value.
If Novo is failing to close above 976.30 and instead slides lower it could test the lower rising trendline. A break of the trendline the key support at around 730.60 could be tested.
Next couple of weeks could be decisive for the medium-to longer-term trend.

 

RSI divergence explained: When instrument price is making a new high/low but RSI values are not making new high/low at the same time. That is a sign of imbalance in the market and an weakening of the uptrend/downtrend. Divergence or imbalance in the market can go on for quite some time but not forever. It is an indication of an exhaustion of the trend



Author is holding a long position in Novo
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.